Associated Papers
The impact of genetic variability on Alzheimer's therapies: obstacles for pharmacogenetic progress.
Cacabelos R et al.
Expert Opinion on Drug Metabolism & Toxicology, 2025
Discovery of a novel homocysteine thiolactone hydrolase and the catalytic activity of its natural variants.
Hou S et al.
Protein Science : a Publication of the Protein Society, 2024
Pharmacogenetics of anxiety and depression in Alzheimer's disease.
Cacabelos R et al.
Pharmacogenomics, 2023
Functional Study of Carboxylesterase 1 Protein Isoforms.
Wang X et al.
Proteomics, 2019
Effect of carboxylesterase 1 c.428G > A single nucleotide variation on the pharmacokinetics of quinapril and enalapril.
Tarkiainen EK et al.
British Journal of Clinical Pharmacology, 2015
Select a paper to view details